In this episode, Zoe Jett Black Lee (Female Transformation Coach) joins me to unpack how gut health and stress play a huge role in your clients’ fat loss results - and what every coach should know before putting a client into a deficit.

We cover how chronic stress, under-eating, and poor food diversity can impact digestion, recovery, and hormones - and how those factors can stall progress in a physique phase. Zoe also shares practical, within-scope strategies for PTs to help clients support their gut, regulate stress, and approach fat loss in a way that’s both effective and sustainable.

If you want to help your clients achieve physique results without sacrificing their health, this episode will give you the tools to coach smarter, not harder.

Listen on: Apple Podcasts Spotify

Episode Summary:
In this episode, Travis speaks with Ted McGill, founder of Biov8, a company specialising in peptide therapeutics and advanced health solutions. The discussion explores the emerging field of peptide medicine — what peptides are, how they work, and the evidence behind their various applications. Ted shares insights on peptide use and efficacy, how they relate to GLP-1 medications, and why uptake among medical professionals has been relatively slow despite promising results. The conversation also looks ahead to future innovations and potential uses for peptides in recovery, longevity, and performance.

Disclaimer: Ted McGill is not a doctor or medical practitioner. Peptides are prescription medications and should only be used under the guidance of a qualified healthcare provider. This episode is for informational purposes only and is not intended as medical advice.

In this episode, Travis speaks with Professor Boyd Swinburn, Professor of Population Nutrition and Global Health at the University of Auckland and a leading international expert on obesity prevention. The conversation covers the global rise in obesity, the policy approaches different countries are using to combat it, and the drivers that make modern environments so obesogenic. Boyd also shares his perspective on how GLP-1 medications might influence public health policy and what role they could play in the future of obesity management worldwide.

Listen on: Apple Podcasts Spotify